InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Dable Habib J, Chairman & CEO. Director active across 2 companies, notably Acceleron Pharma INC. Aggregated, 8 filings have been recorded. Activity tracked since 1 July 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
3,902 shares@ US$128.12100.0% of flowCommon StockSEC:0001415889-25-018073:0
2,242 shares0Common StockSEC:0001415889-24-016979:0
2,600 shares0Common StockSEC:0001415889-23-010260:0
3,900 shares0Common StockSEC:0001415889-22-006974:0
98,450 sharesCommon StockSEC:0001104659-21-142265
98,450 sharesCommon StockSEC:0001104659-21-142265:0
57,814 shares@ US$35.0450.0% of flowCommon StockSEC:0001179110-21-007353:0
57,814 shares@ US$35.0450.0% of flowCommon StockSEC:0001179110-21-007353
8 of 8 declarations
About Dable Habib J
Habib J. Dable is the CEO and President of Acceleron Pharma Inc. He leads the company by overseeing its operations, strategy, and development. His leadership is essential for the growth and success of the organization.
